Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01321-2024. Print 2024 Oct.
The right ventricle and its stress response is perhaps the most important arbiter of survival in patients with pulmonary hypertension of many causes. The physiology of the cardiopulmonary unit and definition of right heart failure proposed in the 2018 World Symposium on Pulmonary Hypertension have proven useful constructs in subsequent years. Here, we review updated knowledge of basic mechanisms that drive right ventricular function in health and disease, and which may be useful for therapeutic intervention in the future. We further contextualise new knowledge on assessment of right ventricular function with a focus on metrics readily available to clinicians and updated understanding of the roles of the right atrium and tricuspid regurgitation. Typical right ventricular phenotypes in relevant forms of pulmonary vascular disease are reviewed and recent studies of pharmacological interventions on chronic right ventricular failure are discussed. Finally, unanswered questions and future directions are proposed.
右心室及其应激反应可能是多种原因导致肺动脉高压患者生存的最重要决定因素。心肺单元的生理学和 2018 年世界肺动脉高压研讨会提出的右心衰竭定义在随后的几年中被证明是有用的构建。在这里,我们回顾了在健康和疾病中驱动右心室功能的基本机制的最新知识,这些知识可能对未来的治疗干预有用。我们进一步将新的右心室功能评估知识置于临床医生易于获得的指标和对右心房及三尖瓣反流作用的更新理解的背景下。我们回顾了相关形式的肺血管疾病中的典型右心室表型,并讨论了慢性右心衰竭的药物干预的最新研究。最后,提出了未解决的问题和未来的方向。